Normunity Revenue and Competitors
Estimated Revenue & Valuation
- Normunity's estimated annual revenue is currently $1.7M per year.
- Normunity's estimated revenue per employee is $77,500
Employee Data
- Normunity has 22 Employees.
- Normunity grew their employee count by 5% last year.
Normunity's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President and Founding CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | SVP, CMC, Manufacturing and Nonclinical Development | Reveal Email/Phone |
4 | SVP Clinical Development | Reveal Email/Phone |
5 | Head Program Leadership | Reveal Email/Phone |
6 | Head Clinical Operations | Reveal Email/Phone |
7 | Associate Director Immuno-Oncology | Reveal Email/Phone |
8 | Senior Director Immunology | Reveal Email/Phone |
9 | Executive Director, Program Management & Business Operations | Reveal Email/Phone |
10 | Senior Research Associate | Reveal Email/Phone |
Normunity Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Normunity?
Normunity, Inc., is a biotechnology company creating a new class of precision immuno-oncology medicines, called immune normalizers, that target novel mechanisms that free the body’s normal immunity against cancer. Based on an ongoing, interactive academic-biotech alliance with the lab of Dr. Lieping Chen at Yale School of Medicine, Normunity is targeting newly-discovered mechanisms of immune disruption in cancer based on proprietary discovery platforms that elucidate the complex interactions between human cancer and the immune system. The company is advancing an emerging pipeline of immune normalizers, including initial drug programs that target mechanisms that drive the exclusion of T-cells from immune-sensitive tumors and other mechanisms that are barriers to normal immune function in cancer. Normunity is located in Boston, Mass. and West Haven, Conn.
keywords:N/A
N/A
Total Funding
22
Number of Employees
$1.7M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.5M | 22 | 16% | N/A |
#2 | $2.7M | 22 | 16% | $17.1M |
#3 | $1.5M | 22 | -15% | $6.8M |
#4 | $3.9M | 22 | -4% | N/A |
#5 | $1.8M | 22 | -24% | N/A |